Hypofractionated IMRT-IGRT With Internal Markers in Prostate Cancer Treatment: Mature Results

被引：0

作者：

Albarran, J. Valero ^{[1
]}

Montero, A. ^{[1
]}

Sanchez, E. ^{[1
]}

Acosta, A. ^{[1
]}

Alvarez, B. ^{[1
]}

Chen, X. ^{[1
]}

Hernando, O. ^{[1
]}

Perez, J. M. ^{[1
]}

Zucca, D. ^{[1
]}

Lapez, M. ^{[1
]}

Ciervide, R. ^{[1
]}

Aranda, M. D. L. O. Garcia ^{[1
]}

Garcia, J. ^{[1
]}

Leton, P. Fernandez ^{[1
]}

Rubio, C. ^{[1
]}

机构：

[1] Hosp Univ HM Sanchinarro, Madrid, Spain

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期

关键词：

D O I：

10.1016/j.ijrobp.2017.06.1244

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2641

引用

页码：E268 / E269

页数：2

共 50 条

[41] Hypofractionated IMRT treatment delivery for breast cancer patients in prone position
Vieira, S.
Moser, E. C.
Varandas, C.
Soares, A.
Stroom, J. C.
Machado, A.
Marques, J.
Mateus, D.
Vasconcelos, A. L.
Greco, C.
RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S77 - S77
[42] Introduction of VMAT, IGRT, and IMRT-Reduced Acute GI Toxicity in Prostate Cancer Patients
Pos, F. J.
Lebesque, J.
Incrocci, L.
Wortel, R.
Heemsbergen, W.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S418 - S418
[43] Comparison of combined IMRT and IGRT with conventional 3D-CRT in the irradiation of prostate cancer
Hodapp, Norbert
STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (05) : 431 - 432
[44] MRI only based planning to decrease toxicity in prostate cancer IMRT/IGRT: a dosimetric study
Stephane, K.
Houssayni, A.
Cassard, U.
Barateau, A.
Duverge, L.
Largent, A.
Acosta, O.
Nunes, J.
Messai, T.
Simon, A.
Dowling, J.
Perichon, N.
De Crevoisier, R.
RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S798 - S799
[45] Acute and late toxicity of hypofractionated RT for localized prostate cancer: IMRT vs Tomotherapy
Rese, A.
Pastore, F.
Panelli, G.
Pepe, A.
Toledo, D.
Francomacaro, F.
Iorio, V.
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S822 - S822
[46] Pelvic nodal dose escalation in conjunction with hypofractionated IMRT for high risk prostate cancer
Adkison, J. B.
Patel, R. R.
Bentzen, S. M.
Hong, T. S.
McHaffie, D. R.
Ritter, M. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S305 - S305
[47] IGRT for prostate cancer n results from the CHHiP IGRT phase II sub-study
Dearnaley, D.
Griffin, C. L.
Syndikus, I.
Scrase, C.
Thomas, S.
Naismith, O.
Mayles, P.
Staffurth, J.
Hall, E.
RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S59 - S59
[48] HYPOFRACTIONATED IMAGE GUIDED IMRT FOR PROSTATE CANCER: PHILIPPINE'S FIRST CLINICAL EXPERIENCE
Banuelos, G.
Aguilar, C.
Cruz, M.
Olvina, M.
Sarmiento, T.
Tangco, E.
Arriola, N.
De Villeres, C.
RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S382 - S383
[49] CASPIR Trial: Calculi as an alternative to fiducial markers for IGRT in localised prostate cancer
O'Neill, A.
King, R.
Crowther, K.
Osman, S.
Jain, S.
Hounsell, A. R.
O'Sullivan, J. M.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S186 - S186
[50] Hypofractionated Simultaneous Integrated Boost IMRT in high risk prostate cancer - A novel approach
Sashidharan, S.
Beena, K.
Chelakkot, P. G.
Madhavan, R.
Menon, D.
Makuny, D.
RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S636 - S636

← 1 2 3 4 5 →